Search Results

Founders Metals Hits 6.0 Metres of 94.69 g/t Gold and 9.0 Metres of 22.84 g/t Gold on Further Northwest Expansion Vancouver, British Columbia--(Newsfile Corp. - December 7, 2023) - Founders Metals Inc. (TSXV: FDR) (OTCQX: FDMIF) (FSE: 9DL0) ("Founders" or the "Company") announces drill core assay results from the Antino Gold Project in southeastern Suriname. The Company reports multiple high-grade gold intervals from further NW into the Froyo-Ginger Connector Zone including, 9.0 metres (m) of 22.84 grams per tonne (g/t) gold (Au) and 6.0 m of 94.69 g/t Au with a property-wide record assay of 434.98 g/t Au over 1 metre. Highlights New highest grade gold assay in the property's history at 434.98 g/t Au over 1.0 metre Drill hole GG001 hits multiple high-grade gold zones (Table 1, Figures 1-2), including: 9.0 m of 22.84 g/t Au from 125 m down hole 6.0 m of 94.69 g/t Au including 1.0 m of 434.98 g/t Au from 152 m down hole Two additional zones including, 6.0 m of 4.47 g/t Au from 41.1 m down hole and, 6.0 m of 2.92 g/t Au from 193 m down hole Further extension of ultra high-grade gold zone into Ginger prospect area Figure 1. Upper Antino area plan map. Long section line A-A' corresponds to Figure 2. To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/7574/190215_0018281f5462282d_001full.jpg Colin Padget, Founders' CEO and President, commented, "With gold grades reaching almost 13 ounces per ton, today's results are a spectacular example of the high-grade gold mineralization at Upper Antino. We are also very excited to see additional gold zones away from the main structure as these potentially represent a much broader mineralized footprint than previously recognized." Mr. Padget continued, "As we head into 2024, our access to rapid assay turnaround times will allow us to continue providing consistent drilling and exploration updates to shareholders. Also, the combination of our recent financing plus the over $7 million of deep-in-the-money warrants, places Founders in an excellent position to meet or exceed our 2024 exploration goals, including up to 30,000 metres of diamond drilling. We plan to release Founders' 2024 exploration strategy in the coming weeks." *Intervals are core length and estimated to represent 85% or more of true width based on current drill data Figure 2. Updated Froyo-Ginger Long Section To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/7574/190215_0018281f5462282d_002full.jpg *Intervals are core length and estimated to represent 85% or more of true width based on current drill data Table 1. Assay results from drill hole GG001 About Founders Metals Inc. Founders Metals is a Canadian exploration company with properties in North and South America. The Company's major focus is on acquiring and advancing gold projects in the Guiana Shield. Its flagship asset is the 20,000 ha Antino Gold Project in Suriname where artisanal surface/alluvial mining has produced over 500,000 gold ounces to date1. Using its own diamond drilling equipment, the Company has drilled over 10,000 m in 2023 and is fully financed for up to 30,000 m in 2024. 1 2022 Technical Report - Antino Project; Suriname, South America. K. Raffle, BSc, P. Geo & Rock Lefrançois, BSc, P.Geo. Figure 3. The Antino Gold Project To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/7574/190215_0018281f5462282d_003full.jpg Quality Assurance and Control Results from samples were analyzed at FILAB Suriname, a Bureau Veritas Certified Laboratory in Paramaribo, Suriname (a commercial certified laboratory under ISO 9001:2015). Samples are crushed to 75% passing 2.35 mm screen, riffle split (700 g) and pulverized to 85% passing 88 µm. Samples were analyzed using a 50 g fire assay (50 g aliquot) with an Atomic Absorption (AA) finish. For samples that return assay values over 10.0 grams per tonne (g/t), another cut was taken from the original pulp and fire assayed with a gravimetric finish. Founders Metals inserts blanks and certified reference standards in the sample sequence for quality control. External QA-QC checks are performed at ALS Global Laboratories (Geochemistry Division) in Vancouver, Canada (an ISO/IEC 17025:2017 accredited facility). A secure chain of custody is maintained in transporting and storing of all samples. Drill intervals with visible gold are assayed using metallic screening. Rock chip samples from outcrop/bedrock are selective by nature and may not be representative of the mineralization hosted on the project. Qualified Persons The technical content of this news release has been reviewed and approved by Michael Dufresne, M.Sc., P.Geol., P.Geo., a qualified person as defined by National Instrument 43-101. ON BEHALF OF THE BOARD OF DIRECTORS, Per: "Colin Padget" Colin Padget President, Chief Executive Officer, and Director Founders Metals Contact Information Dave Burwell, VP, Corporate Development Tel: 403 410 7907 | daveb@fdrmetals.com Cautionary Statement Regarding Forward-Looking Information This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-Looking information includes, without limitation, statements regarding the use of proceeds from the Company's recently completed financings and the future or prospects of the Company. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect ", "is expected ", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-Looking statements are necessarily based upon a number of assumptions that, while considered reasonable by management, are inherently subject to business, market, and economic risks, uncertainties, and contingencies that may cause actual results, performance, or achievements to be materially different from those expressed or implied by forward-looking statements. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, other factors may cause results not to be as anticipated, estimated, or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Other factors which could materially affect such forward-looking information are described in the risk factors in the Company's most recent annual management discussion and analysis. The Company does not undertake to update any forward-looking information except in accordance with applicable securities laws. All material information on Founders Metals can be found at www.sedarplus.ca. SOURCE

VANCOUVER, BC / ACCESSWIRE / December 7, 2023 / Pegasus Resources Inc. (TSX-V:PEGA)(Frankfurt:0QS0)(OTC PINK:SLTFF) (the "Company" or "Pegasus") is pleased to announce the analytical results from its 2023 ground exploration program at the Punch Bowl Property, Golden Project in east-central British Columbia (See news release October 06, 2023). Exploration Highlights: Abbreviated late fall reconnaissance program included 25 rock samples, with seven (7) having returned greater than 0.13 g/t Au Three samples returned values of 4.70 g/t Au, 3.87 g/t Au and 1.61 g/t Au The 2023 samples extended mineralization of the gold bearing quartz vein set to approximately 200 m along strike Located previously unsampled mineralized quartz vein(s) on McGilvary Ridge A late fall exploration program was carried out at the company's Punch Bowl Property on October 6th and 7th, 2023, with a total of 25 grab samples collected (Figure 1). Due to the unprecedented Forest Fire activity across Canada in 2023, the company was limited to an abbreviated exploration program which had been scheduled for earlier in the field season. Samples targeted pyrite-bearing quartz veins within northwest-southeast trending recessive phyllitic lenses that have historically returned elevated gold values of up to 573.7 g/t Au (Shaw, 1989). Overall, the program was successful in extending mineralization along strike of known auriferous veins, in addition to locating a previously unsampled mineralized quartz vein. "The Company is greatly encouraged by the results from the exploration campaign at the Punch Bowl Property," stated Chris Timmins, President and CEO of Pegasus. "The assays show that the mineralization observed within the quartz veins is relatively continuous along strike, and the newly discovered quartz vein displays the potential for multiple mineralized zones on McGillivray Ridge. We look forward to continuing to advance this project during the summer of 2024." Figure 1: 2023 sample locations with historical assay results. Photos (left): Sample 150878 returned 4.70 g/t Au from a 0.4m wide quartz vein (right): newly discovered 0.2m wide mineralized quartz vein which returned 1.61 g/t Au About the Golden Project: The Golden Project is comprised of three distinct claim groups, from south to North: Gold Mountain, Vertebrae Ridge and Punch Bowl. Punch Bowl: The Punch Bowl Property consists of three mineral claims totalling 3,079 ha and is approximately 90 km NW of the company's Gold Mountain Property and 140 km NW of Golden, BC. The property surrounds the historic Punch Bowl Showing, where discrete gold in quartz veins are hosted within quartzites and pelites of the Early Cambrian McNaughton Formation. Vertebrae Ridge: The Vertebrae Ridge property is comprised of four claims encompassing about 5,324 ha (13,156 acres) roughly 81 kilometers northwest of Golden, BC. During August 2021 ground exploration resulted in the extension of known polymetallic mineralization trends, the confirmation of significant mineralization continuity at historically sampled locations, and the discovery of the Canon Cu-Au Zone. The Company believes the newly discovered Canon Zone may be related to a large oval, alkaline intrusion located a short distance west of the mineralized area. Gold Mountain: The Gold Mountain Property is an early-stage gold/silver property located approximately 50 km NW of Golden, BC, just north of Highway 1. The property comprises two mineral claims encompassing 802 ha and covering the historic Grizzly Occurrence, which consists of gold and silver mineralization within polymetallic quartz/carbonate veins. Quality Assurance / Quality Control All samples were collected in the field using a hammer and chisel. Locations were obtained using a handheld GPS or tablet, with samples placed in pre-labelled sample bags. Metal tags with the sample numbers and flagging tape were left at each sample location. A Quality Assurance/Quality Control protocol was incorporated into the program and included the insertion of silica blanks at a rate of approximately 15%. Samples were transported to SGS Canada's laboratory in Burnaby, BC, for standard sample preparation (code PRP89), which includes drying at 105°C, crushing to 75% passing 2mm, riffle splitting 250 g, and pulverizing to 85% passing 75 microns. They were analyzed for multi-element (code GE_ARM3V25) and Au by fire assay (code GE_FAA30V5). Management cautions that prospecting surface rock samples and associated assays, as discussed herein, are selective by nature and represent a point location and, therefore, may not necessarily be fully representative of the mineralized horizon sampled. NI 43-101 Disclosure The technical content of this news release has been reviewed and approved by Nathan Schmidt, P. Geo., Senior Geologist for Dahrouge Geological Consulting Ltd., and a Qualified Person under National Instrument 43-101, who has prepared and/or reviewed the content of this press release. Correction/clarification October 26, 2023, news release should read: Under this agreement, RCSI will provide market-making services in accordance with TSX Venture Exchange Policy 3.4. This engagement initially spans twelve months and is subject to renewal on a month-to-month basis thereafter, allowing flexibility in our collaboration. In recognition of RCSI's services, Pegasus will compensate RCSI with an aggregate fee of $5,000 per month during the 12-month term, paid quarterly. About Pegasus Resources Inc. Pegasus Resources Inc. is a diversified Junior Canadian Mineral Exploration Company with a focus on uranium, gold, and base metal properties in North America. The Company is also actively pursuing the right opportunity in other resources to enhance shareholder value. For additional information, please visit the Company at www.pegasusresourcesinc.com. On Behalf of the Board of Directors: Christian Timmins President, CEO and Director Pegasus Resources Inc. 700 - 838 West Hastings Street Vancouver, BC V6C 0A6 PH: 1-403-597-3410 X: https://twitter.com/MrChris_Timmins X: https://twitter.com/pegasusresinc E: info@pegasusresourcesinc.com Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release. Forward Looking Statements Statements included in this announcement, including statements concerning the Company's plans, intentions, and expectations, which are not historical in nature are intended to be, and are hereby identified as, "forward-looking statements." Forward-looking statements may be identified by words including "anticipates," "believes," "intends," "estimates," "expects" and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company's future operations and business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements. SOURCE

VANCOUVER, BC / ACCESSWIRE / November 30, 2023 / Pegasus Resources Inc. (TSXV:PEGA)(FRA:OQS2)(OTC PINK:SLTFF) (the "Company" or "Pegasus") is thrilled to announce a significant milestone in its strategic plans to discover uranium. The Company has successfully staked new land in Utah adjacent to its 100% owned Energy Sands property, bolstering its portfolio with the addition of 48 new lode claims. The mining claims were registered directly by Pegasus at the BLM office in Salt Lake, Utah. Key Highlights: Land Expansion: Pegasus has significantly increased the footprint of its Energy Sands property by an impressive 160%. Mapping and Sampling Program: The next phase of development involves initiating a comprehensive mapping and sampling program to delineate potential drill targets. Drilling Permit Application: Following the mapping and sampling phase, Pegasus plans to submit applications for drilling permits, a crucial step in advancing the exploration process. Q2/Q3 Drill Program: These initiatives aim to make the Energy Sands property drill-ready by the second quarter of the upcoming year. This expansion aligns with Pegasus' commitment to strategic exploration and the responsible development of valuable uranium resources. The Company remains dedicated to maintaining transparency and providing stakeholders with updates on the progress of this exciting venture. About Energy Sands Project: The Energy Sands Project, a promising venture under the banner of Pegasus, is strategically positioned within the prolific Tidwell Mineral Belt of the San Rafael Uranium District in east-central Utah. Hosted within the Salt Wash Member of the Jurassic Morrison Formation, this project is characterized by significant uranium mineralization. Geological Characteristics: Uranium mineralization within the Tidwell Mineral Belt follows a distinct orientation, manifesting in a series of roughly northeast trends. Individual mineralized bodies in the area are tabular to lenticular, with their long axes aligned along these trends. This geological feature shapes the potential for resource exploration and development of economical uranium deposits. To confirm the continuity of the Tidwell Mineral Belt on the property a field mapping and sampling program will commence in Q1 2024. Proximity to Western Uranium's San Rafael Project: The Energy Sands Project gains prominence not only from its intrinsic geological value but also due to its strategic location. It is situated on-trend and is approximately 4 kilometres from Western Uranium's San Rafael Uranium Project. A noteworthy comparison with Western Uranium's San Rafael Project reveals the potential of the Energy Sands Project. The San Rafael Project is located in Emery County, Utah. The core uranium deposit of the San Rafael Uranium Project is the Deep Gold deposit. The Historic Indicated Mineral Resource (CIM Definition) for the entire San Rafael Uranium Project comprises 479,050 tons @ 0.25% U3O8 containing 2,415,300 lbs U3O8 and a Historic Inferred Mineral Resource (CIM Definition) of 92,350 tonnes @ 0.32% U3O8 containing 587,800 lbs U3O8. Historic vanadium resource exists at the project.(based on the Nov-19, 2014 Technical Report filed by Western Uranium) Additionally, it is noteworthy that Western Uranium & Vanadium Corp. is advancing a state-of-the-art mineral processing plant in Utah. Utilizing the latest technology, this facility, including Western's patented Kinetic Separation process, is set to recover uranium, vanadium, and cobalt from ore. The capacity of the Facility can be scaled up as Western develops additional mines and to process ore for other mining companies requiring third-party processing services. (Western Uranium New release January 23, 2023) Historical Significance: The Energy Sands Project has a historical backdrop, as outlined in a report archived by the United States Geological Survey (USGS). Small-scale uranium production by the Minerals Corporation of America occurred between 1953 and 1956, totalling 51.8 tons at an impressive grade of 0.373% U3O8 and 1.10% V2O5 (Byers & Robertson, 1956). Pegasus is now poised to unlock the potential of the Energy Sands Project, building on its geological promise, strategic location, and historical significance. As the Company advances exploration and development initiatives, stakeholders can anticipate exciting developments in this promising uranium project. NI 43-101 Disclosure The technical content of this news release has been reviewed and approved by Jacob Anderson, CPG, MAusIMM, Resource Geologist for Dahrouge Geological Consulting USA Ltd., and a Qualified Person under National Instrument 43-101, who has prepared and/or reviewed the content of this press release. About Pegasus Resources Inc. Pegasus Resources Inc. is a diversified Junior Canadian Mineral Exploration Company with a focus on uranium, gold, and base metal properties in North America. The Company is also actively pursuing the right opportunity in other resources to enhance shareholder value. For additional information, please visit the Company at www.pegasusresourcesinc.com. On Behalf of the Board of Directors: Christian Timmins President, CEO and Director Pegasus Resources Inc. 700 - 838 West Hastings Street Vancouver, BC V6C 0A6 PH: 1-403-597-3410 X: https://twitter.com/MrChris_Timmins X: https://twitter.com/pegasusresinc E: info@pegasusresourcesinc.com Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release. Forward Looking Statements Statements included in this announcement, including statements concerning the Company's plans, intentions, and expectations, which are not historical in nature are intended to be, and are hereby identified as, "forward-looking statements." Forward-looking statements may be identified by words including "anticipates," "believes," "intends," "estimates," "expects" and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company's future operations and business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements. SOURCE

Click here to listen to the replay

VANCOUVER, British Columbia, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company focused on the development of novel DNA-damage response inhibitors (DDRi) to address high unmet medical needs in the treatment of cancer, today announced the appointment of Prof. Artem Cherkasov to the Company’s Scientific Advisory Board. Prof. Cherkasov is a Professor in the Department of Urologic Sciences, Faculty of Medicine at the University of British Columbia, and Senior Scientist at the Vancouver Prostate Centre and Canada Research Chair in Precision Cancer Drug Design. “I am pleased to welcome Prof. Cherkasov to our scientific advisory board,” said Mads Daugaard, Rakovina Therapeutics’ president and chief scientific officer. “Art’s groundbreaking contributions in AI-driven drug discovery and his commitment to advancing scientific frontiers make him an invaluable addition to our team. His trailblazing work, from licensing multiple drug candidates to pioneering AI-based platforms for global health crises, embodies innovation and excellence. We're honoured to welcome Dr. Cherkasov, whose expertise and vision will undoubtedly propel our mission to transform and extend the lives of patients with cancer.” About Prof. Artem Cherkasov Prof. Cherkasov’s research interests include artificial intelligence (AI) and computer-aided drug discovery (CADD), structure-activity modelling, drug reprofiling, new cancer therapeutics discovery and development of novel CADD tools and applications. Prof. Cherkasov has co-authored more than 200 research papers, 80 patent filings and several prominent book chapters. During his tenure at UBC, Prof. Cherkasov has licensed multiple drug candidates to major international venture capital funds and big pharma companies, including an androgen receptor inhibitor to Roche in 2015 for USD$142 million – a record amount for Canadian academic institutions. In response to the global COVID-19 pandemic, Prof. Cherkasov led a team employing a novel AI-based platform to process billions of compounds. Within a week they had identified the top 1,000 potential ligands, which they shared with the global scientific community. “Prof. Cherkasov's unparalleled expertise adds a unique dimension to the Rakovina Therapeutics team and complements our recent SAB appointment of Prof. Petra Hamerlik, former CNS Cancer Bioscience Lead at AstraZeneca," stated Jeffrey Bacha, executive chairman of Rakovina Therapeutics. "Their contribution to our research promises to amplify and expedite the development of our pioneering DDRi pipeline.” About Rakovina Therapeutics Inc. Rakovina Therapeutics Inc. is focused on the development of new cancer treatments based on novel DNA-damage response (DDR) technologies. The Company has established a pipeline of novel DNA-damage response inhibitors with the goal of advancing one or more drug candidates into human clinical trials and obtaining marketing approval for new cancer therapeutics from Health Canada, the United States Food and Drug Administration and similar international regulatory agencies. Further information may be found at www.rakovinatherapeutics.com. Additional Information The TSXV has neither approved nor disapproved the content of this press release. Neither the TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. Notice regarding forward-looking statements: This release includes forward-looking statements regarding the Company and its respective business, which may include, but is not limited to, statements with respect to the proposed business plan of the Company and other statements. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “is expected”, “expects”, “scheduled”, “intends”, “contemplates”, “anticipates”, “believes”, “proposes” or variations (including negative variations) of such words and phrases, or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such statements are based on the current expectations of the management of the Company. The forward-looking events and circumstances discussed in this release may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company, including risks regarding the medical device industry, economic factors, regulatory factors, the equity markets generally and risks associated with growth and competition. Although the Company has attempted to identify important factors that could cause actual actions, events, or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events, or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. The reader is referred to the Company’s most recent filings on SEDAR for a more complete discussion of all applicable risk factors and their potential effects, copies of which may be accessed through the Company’s profile page at www.sedar.com. Contact: Rakovina Therapeutics Inc. David Hyman Chief Financial Officer Email: info@rakovinatherapeutics.com Investor Relations Contact IR@rakovinatherapeutics.com Media Contact MEDIA@rakovinatherapeutics.com SOURCE

VANCOUVER, British Columbia, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company focused on the development of novel DNA-damage response (DDR) inhibitors to address high unmet medical needs in the treatment of cancer, today announced the appointment of Prof. Petra Hamerlik, Chair of Translational Neuro-Oncology at the University of Manchester and former CNS Cancer Bioscience Lead at AstraZeneca plc, to its Scientific Advisory Board (“SAB”). “We are extremely pleased to add Prof. Hamerlik to our SAB as a researcher with a deep understanding of the DNA-damage response field,” stated Jeffrey Bacha Rakovina Therapeutics’ executive chairman. “As we continue to focus our efforts squarely on the advancement of our lead kt-3000 program toward human clinical trials, Prof. Hamerlik’s experience in the development of leading drugs in the DNA-damage response field will offer significant insights and guidance toward our ultimate success in delivering new therapies to improve the lives of patients suffering from cancer.” In June 2023, Rakovina Therapeutics researchers published a manuscript in the Journal of Clinical Cancer Research reporting the characterization of a kt-3000 lead candidate with dual activity against PARP and HDAC enzymes as a potential treatment for Ewing sarcoma and other treatment-resistant cancers. “Rakovina Therapeutics has been working on cutting-edge DNA-damage response inhibitors since its inception,” said Prof. Hamerlik. “I am excited to join the Rakovina Therapeutics’ Scientific Advisory Board and bring both my academic and industrial experience to the Company at this important time in its development. I look forward to contributing to Rakovina Therapeutics’ success.” Prof. Hamerlik joins existing Scientific Advisory Board members, including Dr. Dennis Brown PhD, Dr. Leonard Post PhD, Dr. Neil Sankar MD and Dr. Wang Shen PhD, each of whom bring decades of drug discovery and development experience to their advisory roles. “We are delighted to have Prof. Hamerlik join our esteemed Scientific Advisory Board,” stated Prof. Mads Daugaard, President, and Chief Scientific Officer of Rakovina Therapeutics. “Her extensive experience and expertise in PARP and DNA-damage response inhibitors are valuable additions to our team. This expertise is particularly complementary to Dr. Post’s accomplishments in the successful development and commercialization of Pfizer’s Talzenna® (talazoparib), one of the four FDA-approved PARP-inhibitors.” About Petra Hamerlik, PhD Prof. Petra Hamerlik, PhD currently serves as Chair of Translational Neuro-Oncology at the University of Manchester where she has established a research team that is focused on investigating the biology of malignant brain tumors and developing innovative approaches for their early detection. She previously held a joint appointment as a Principal Scientist and CNS cancer Bioscience Lead at AstraZeneca where she contributed to the development of brain-penetrant DNA repair inhibitors for targeting primary brain tumours and brain metastases. Prior to her role at AstraZeneca, Professor Hamerlik was Group Leader for the Brain Tumour Biology laboratory within the Danish Cancer Research Centre and Associate Professor at the University of Copenhagen. During this time, she led research focused on improving the understanding of DNA damage response and demonstrating the potential of enhanced efficacy of combining PARP and HDAC inhibition in the treatment of cancer. About Rakovina Therapeutics Inc. Rakovina Therapeutics Inc. is focused on the development of new cancer treatments based on novel DNA-damage response (DDR) technologies. The Company has established a pipeline of novel DNA-damage response inhibitors with the goal of advancing one or more drug candidates into human clinical trials and obtaining marketing approval for new cancer therapeutics from Health Canada, the United States Food and Drug Administration and similar international regulatory agencies. Further information may be found at www.rakovinatherapeutics.com. Additional Information The TSXV has neither approved nor disapproved the content of this press release. Neither the TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. Notice regarding forward-looking statements: This release includes forward-looking statements regarding the Company and its respective business, which may include, but is not limited to, statements with respect to the proposed business plan of the Company and other statements. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “is expected”, “expects”, “scheduled”, “intends”, “contemplates”, “anticipates”, “believes”, “proposes” or variations (including negative variations) of such words and phrases, or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such statements are based on the current expectations of the management of the Company. The forward-looking events and circumstances discussed in this release may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company, including risks regarding the medical device industry, economic factors, regulatory factors, the equity markets generally and risks associated with growth and competition. Although the Company has attempted to identify important factors that could cause actual actions, events, or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events, or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. The reader is referred to the Company’s most recent filings on SEDAR for a more complete discussion of all applicable risk factors and their potential effects, copies of which may be accessed through the Company’s profile page at www.sedar.com. Contact: Rakovina Therapeutics Inc. David Hyman Chief Financial Officer Email: info@rakovinatherapeutics.com Investor Relations Contact IR@rakovinatherapeutics.com Media Contact MEDIA@rakovinatherapeutics.com SOURCE

Vancouver, British Columbia--(Newsfile Corp. - November 15, 2023) - Golden Goliath Resources Ltd. (TSXV: GNG ) (OTC Pink: GGTHF) (FSE: GGZ) Golden Goliath Resources is pleased to report on the interpretation of the geophysics survey completed on their Ernest and Victory 21 properties near the Manicouagan impact crater in central Quebec. The interpretation was completed by Jean-M Hubert, eng. The Manicouagan Project consists of four properties covering anomalous Rare Earth Element occurrences just to the south of the Manicouagan impact crater. The initial program consisted of ground geophysics, geology, and geochemistry to identify the source of lake sediment anomalies and to assess previous anomalous rock samples. Figure 1: Manicouagan Project To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/4761/187442_5c36c191645d8b7e_002full.jpg The rock and till sampling program reported on October 12 news release, confirmed the presence of anomalous values in most of the rare earth elements along with Rubidium, Strontium, Thorium, and Zirconium. Mapping found significant thicknesses and generations of pegmatites intruding into the host gniess and granites. Fig 2 Ernest Property: Radiometric analysis identifying high priority anomalies (letters) and other areas of interest (red circles) To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/4761/187442_5c36c191645d8b7e_003full.jpg Fig 3 Victory 21Property: Radiometric analysis identifying high priority anomalies (letters) and other areas of interest (red circles) To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/4761/187442_5c36c191645d8b7e_004full.jpg On the Ernest property the interpretation of the geophysics data identified 10 high priority anomalies and another 30 anomalies of interest. On the Victory 21 property 14 high priority targets were identified with a further 9 anomalies of interest. In the report Jean-M Hubert notes that the anomalies of interest may be as significant as the high priority anomalies but may be masked by overburden. Starting in late November Golden Goliath will be conducting a detailed drone magnetics survey to outline the units responsible for the anomalous geophysics. In late spring 2024, the Company intends to conduct a trenching and stripping program to expose and sample the anomalous units. With the success of the geophysics survey on Ernest and Victory 21 a geophysics program is planned for the other two Manicouagan projects, Bedard and Citadelle, as soon as conditions allow. Golden Goliath CEO Paul Sorbara said, "The report by Jean-M Hubert confirms the excellent potential of these two properties. The drone MAG survey should also be very helpful. I am confident that we will see similar results from Bedard and Citadelle once we can do the surveys there." This news release has been reviewed by Gordon MacKay, P.Geo., who is acting as QP under the NI 43-101 requirements. On behalf of the Board of Directors Paul Sorbara, MSc, PGeo CEO, Golden Goliath Resources Ltd. About Golden Goliath Golden Goliath Resources Ltd. is a junior exploration company listed on the TSX Venture Exchange (symbol GNG). The Company is focused on exploring and developing the gold and silver potential of properties in the Red Lake District of Ontario. The Company also holds a 100% interest in the San Timoteo property, located in the Sierra Madre Occidental Mountains of northwestern Mexico, as well as NSR royalties on several other nearby properties. To find out more about Golden Goliath visit our website at www.goldengoliath.com. Cautionary Statements Regarding Forward-Looking Information Certain statements included herein may constitute "forward-looking statements". All statements included in this press release that address future events, conditions or results, including in connection with exploration activity, future acquisitions and any financing, are forward-looking statements. These forward-looking statements can be identified by the use of words such as "may", "must", "plan", "believe", "expect", "estimate", "think", "continue", "should", "will", "could", "intend", "anticipate" or "future" or the negative forms thereof or similar variations. These forward-looking statements are based on certain assumptions and analyses made by management in light of their experiences and their perception of historical trends, current conditions and expected future developments, as well as other factors they believe are appropriate in the circumstances. These statements are subject to risks, uncertainties and assumptions, including those mentioned in the Company's continuous disclosure documents, which can be found under its profile on SEDAR (www.sedarplus.ca). Many of such risks and uncertainties are outside the control of the Company and could cause actual results to differ materially from those expressed or implied by such forward-looking statements. In making such forward-looking statements, management has relied upon a number of material factors and assumptions, on the basis of currently available information, for which there is no insurance that such information will prove accurate. All forward-looking statements are expressly qualified in their entirety by the cautionary statements set forth above. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law. FOR MORE INFORMATION CONTACT: Golden Goliath Resources Ltd. J. Paul Sorbara, M.Sc., P.Geo President & CEO Phone: +1(604) 682-2950 Email: jps@goldengoliath.com Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. SOURCE

Latest installation highlights the flexibility of WANDA™ Edmonton, Alberta - November 9, 2023 - Visionstate Corp. (TSXV: VIS) (“Visionstate” or the “Company”), a leading provider of innovative software solutions, is thrilled to announce its latest achievement – a multi-location contract with a large post-secondary institution. This collaboration signifies another “use case” milestone for Visionstate, as it continues to expand the horizons of smart technology solutions. Under this agreement, Visionstate will implement its cutting-edge WANDA™ software for fleet management, revolutionizing the institution's vehicle management processes. This transformative installation will serve more than 500 users across multiple locations, streamlining the check-in/check-out procedures for fleet vehicles and digitizing the storage of crucial information on the WANDA™ portal. "This partnership underscores our commitment to harnessing technology for real-world solutions," said Shannon Moore, President of Visionstate IoT. "We are proud to be at the forefront of transformative fleet management, addressing longstanding challenges and opening doors to predictive maintenance capabilities." Traditionally, paper-based check-in and check-out procedures often resulted in challenges such as misplaced paperwork, missed check-ins, and incomplete records. This innovative installation will resolve these issues by creating a seamless, digital system for fleet management, ensuring transparency and accountability. One of the most exciting aspects of this collaboration is the potential for predictive maintenance. By digitally monitoring the usage and maintenance of the fleet vehicles over time, WANDA™ software will gather valuable insights. These insights will enable the institution to proactively address maintenance needs, reduce downtime, and optimize the performance and longevity of its fleet. Visionstate is excited about the opportunities that this contract brings and is dedicated to continuing its mission of providing innovative solutions that drive efficiency, accountability, and sustainability. About Visionstate Corp. Visionstate Corp. (TSXV: VIS) is a growth-oriented company that invests in the research and development of promising new technology in the realm of the Internet of Things, big data and analytics, and sustainability. Visionstate IoT Inc. is a wholly-owned subsidiary of Visionstate Corp. Through Visionstate IoT Inc., it helps businesses improve operational efficiencies, reduce costs, and elevate customer satisfaction with its state-of-the-art devices that track and monitor guest activities and requests. The footprint of its WANDA™ smart device now extends to hospitals, airports, shopping centres, and other public facilities across and beyond North America. Through building up a collection of synergistic technologies, Visionstate Corp. will continue to innovate, reduce environmental impact, and transform consumer experiences. Issued on behalf of the Board of Directors, “John A. Putters” Visionstate Corp. To learn more, please contact: Visionstate IoT Inc. Shannon Moore, President Email: shannon@visionstate.com Tel: 780-425-9460 CHF Capital Markets Kathy Chapman Email: kc@chfir.com Tel: 416-868-1079 x 234 Twitter: @visionstate Facebook: @visionstate LinkedIn: Visionstate Corp. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements Certain information set forth in this material may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding future financial position, business strategy, use of proceeds, corporate vision, proposed acquisitions, partnerships, joint-ventures and strategic alliances and co-operations, budgets, cost and plans and objectives of or involving the Company. Such forward-looking information reflects management's current beliefs and is based on information currently available to management. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "predicts", "intends", "targets", "aims", "anticipates" or "believes" or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. A number of known and unknown risks, uncertainties and other factors may cause the actual results or performance to materially differ from any future results or performance expressed or implied by the forward-looking information. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company including, but not limited to, the impact of general economic conditions, industry conditions and dependence upon regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by securities laws. SOURCE

One Unique Junior Gold Exploration Company With Production Potential! Sonoro Gold (TSXV:SGO) Departures Capital's Aaron Missere sits down with President and CEO of Sonoro Gold Corp. Kenneth MacLeod SOURCE

Highlights: AI/ML Innovations' minority-owned subsidiary, Tech2heal, chosen to partner with a leading French company in virtual occupational health clinics. Tech2heal's AI-driven healthcare platform forms the technological backbone of the service. TORONTO, ON / ACCESSWIRE / November 9, 2023 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to report the following press release from its minority-owned subsidiary, Tech2heal SAS: Tech2heal, a pioneer in AI-powered healthcare technology, is delighted to reveal its latest in a number of strategic partnerships. This alliance was formed with a leading France-based health service provider (the "Partner"), who specializes in virtual occupational health clinics that specifically focus on enhancing mental health, and addressing sleep disorders, two critical aspects of overall employee well-being. This collaboration marks a significant advancement in the realm of mental health and sleep disorder prevention as it brings together Tech2heal's versatile AI-powered clinical care platform, Alakin, with the Partner's innovative risk prevention solutions, tailored to corporate clients. This alliance underscores the emerging role of technology in addressing mental health and sleep disorders, with the primary goal of improving employee well-being in today's dynamic workplace environment. To maintain certain competitive advantages in the marketplace, the Partner's identity remains undisclosed. Paul Duffy, CEO of AIML, expressed his enthusiasm for this partnership, "We are proud of Tech2heal's many achievements in a short period of time. This most recent partnership demonstrates, once again, the power and versatility of the Alakin dashboard to be readily configured to multiple, diverse healthcare scenarios and revenue streams. While we at AIML directly benefit from this venture through our ownership interest in Tech2heal, we also see potential to redeploy this Alakin business model within North America through our majority-owned subsidiary, AI Rx Inc., which holds exclusive North American rights to Tech2heal's technologies." Highlights of the Partnership 1. Cutting-Edge Solutions: Tech2heal's Alakin platform will provide a robust foundation for the Partner's risk prevention solutions. By leveraging Alakin's highly customizable capabilities, the Partner can tailor their services to meet the unique needs of each employee of their corporate customers. 2. Streamlined Care Pathways: Alakin's user-friendly interface and capacity to create powerful hybrid care pathways were pivotal in the Partner's selection process. This feature will ensure a seamless experience for both patients and healthcare practitioners. 3. Market Acceleration: Tech2heal's Alakin platform empowers the Partner to expedite the introduction of their innovative employee risk prevention solutions to the market, effectively meeting the growing demand for mental health and sleep disorder solutions. 4. Comprehensive Tools: The alliance equips the Partner with a comprehensive suite of healthcare tools designed to address the needs of both patients and healthcare practitioners. This holistic approach ensures that every aspect of employee well-being is considered. Paul Duffy concluded, "Mental health issues and sleep disorders significantly impact lost man-hours and costs for employers globally. This alliance reflects the sea change in attitude regarding how organizations address and prioritize their employees' mental and physical health." About Tech2heal https://www.tech2heal.com/ Tech2heal is a Paris-based company at the vanguard of AI-driven digital health solutions. With an unwavering commitment to innovation, Tech2heal strives to harness cutting-edge technologies to elevate human well-being. The company's expertise spans artificial intelligence, healthcare, and wearable technology, with a mission to revolutionize the future of digital health. About AI/ML Innovations Inc. https://aiml-innovations.com/ AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (95.2% owned by AIML), Tech2Heal (up to 22% ownership rights, with 12.44% currently owned by AIML), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB". On behalf of the Board of Directors Tim Daniels, Executive Chairman For more information about AI/ML Innovations: For detailed information please see AI/ML's website or the Company's filed documents at www.sedar.com. For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. For AI/ML Innovations Investors Certain statements made in this press release that are not based on historical information are forward-looking statements that involve substantial known and unknown risks and uncertainties. This press release contains express or implied forward-looking statements relating to, among other things, AI/ML Innovations' expectations concerning management's plans, objectives and strategies, including strategies for defending the Company's intellectual property. These statements are neither promises nor guarantees but are subject to a variety of risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. AI/ML Innovations Inc. undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise except as expressly required by applicable securities law. Further information regarding the uncertainties and risks can be found in the disclosure documents filed by AI/ML with the securities regulatory authorities, available at www.sedar.com. SOURCE

VICTORIA, BC / ACCESSWIRE / November 8, 2023 / Boron One Holdings Inc. ("Boron One" or the "Company") (TSXV:BONE), a company committed to advancing the decarbonization of our planet through the responsible management of its boron assets, is pleased to announce that it has appointed Follow The Money Investment Group ("FTMIG") as a marketing consultant. FTMIG is a marketing group headquartered in Toronto, Canada which provides relevant content and timely information needed to navigate the ever-changing capital markets. They are dedicated to bringing investors and companies together through strategic social media campaigns that expand their reach and maximize their potential. FTMIG will assist in increasing awareness of the Company using a number of market communications initiatives, including media distribution on multiple on-line channels such as the FTMIG website, social media platforms, and Reddit advertisements. Under the terms of the engagement, FTMIG has been retained for a 12-month period at $74,800 plus direct expenses, to be paid from general corporate funds. On behalf of the Board of Directors, Blake Fallis, General Manager About Boron One Holdings Inc. (formerly known as Erin Ventures Inc.) Boron One Holdings Inc. is a leading company dedicated to advancing the decarbonization of our planet through the responsible utilization of boron assets. With a commitment to environmental stewardship and sustainability, Boron One aims to play a crucial role in reducing the carbon footprint and supporting a cleaner, greener future. Headquartered in Victoria, B.C., Canada, Boron One's shares are traded on the TSX Venture Exchange under the symbol "BONE". For detailed information please see Boron One's website at www.boronone.com or the Company's filed documents at https://www.sedarplus.ca/. For further information, please contact: Boron One Holdings Inc. Blake Fallis, General Manager Phone: 1-250- 384-1999 or 1-888-289-3746 info@boronone.com www.boronone.com Boron's Public Quotations: Canada TSX Venture: BONE Berlin: EKV US: SEC 12G3-2(B) #82-4432ERVFF OTCBB: ERVFF Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. SOURCE

New conductors and fault intersections identified in the East claim block will be focus of the 2024 exploration program Vancouver, BC - Forum Energy Metals Corp. (TSX.V: FMC; OTCQB: FDCFF) (the “Company” or “Forum”) and Traction Uranium Corp. (CSE: TRAC) (OTC: TRCTF) (FRA: Z1K) (“Traction”) are pleased to announce they have completed an initial review of an airborne magnetic, electromagnetic (EM) and radiometric survey on Forum’s 100%-owned Grease River Project, located along the north rim of the Athabasca Basin, Saskatchewan. The survey was conducted over the entire Grease River claims totaling 10,528 hectares along the Grease River Shear Zone (Figure 1). Highlights: East Block The total domain EM data has outlined several prospective conductive trends along and north of the Grease River shear zone. New data highlights the main fault orientations and offsets; this survey has developed targets that can be the focus for future exploration programs. West Block New magnetic and EM data has provided better resolution on the basement geology beneath this underexplored part of the Athabasca Basin. From May 11th to June 23rd, 2023, Axiom Exploration Group Ltd. carried out a helicopter borne 30Hz XciteTM TDEM survey and collected time domain EM, magnetic and radiometric data simultaneously. A total of 1,421 line-km (613 line-km on the West block and 808 line-km on the East Block) were surveyed at a 100 m line spacing and a 1,000 m tie-line spacing. Initial data review has provided better resolution on the basement geology through the detailed magnetic (Figure 2) and EM data. The survey has also outlined several conductive trends that require follow-up in the East block claims (Figure 3). Radiometric data will help map rock units in the East claim block and additional anomalies will be followed up with ground prospecting on both blocks. Next steps will be conducting ground prospecting work, as well as additional geophysical surveys (such as gravity, resistivity) to narrow down the top priority target areas in 2024. Historic prospecting near one of the conductors (SMDI 1577) located up to 0.65% U3O8 in a grab sample composed of quartzite gneiss. Traction entered into an option agreement with Forum whereby Traction is entitled to acquire a 51% interest in the Property by paying an aggregate of $250,000, issuing an aggregate of 1,625,000 common shares and funding an aggregate of $3 million in exploration expenditures on the Property by December 31, 2025. Forum is the Operator during this First Option Period. Traction has the further option to earn up to 100% interest in the project by making $1.7 million in cash payments, 5.5 million share payments and $6 million in exploration up until December 31, 2028. Forum would retain a 2% Net Smelter Return Royalty and $8 million in milestone payments (see News Release dated February 7, 2023). The Grease River Project The Grease River Project is located within the north-central margin of the Athabasca Basin near the community of Fond du Lac. The Grease River Project consists of two separate claim blocks situated along the NE-trending Grease River Shear zone, a major intracontinental shear zone greater than 400 km long. The nearby Fond du Lac unconformity uranium deposit was discovered within the shear zone by Amok Ltd. (“Amok”) and Eldorado Nuclear Ltd. (“Eldorado”) in the 1970s and a historical resource estimate of one million pounds uranium at an average grade of 0.25% U3O8* was disclosed. It was, however, not prepared in accordance with the requirements of National Instrument 43-101 - Standards of Disclosure for Mineral Projects (“NI 43-101”). While the Company believes the historical estimate to be relevant and reasonable‎ given the quality exploration of work completed by Amok / Eldorado‎, a qualified person has not completed sufficient work to verify and classify the historical estimate, therefore, the Company is not treating the historical estimate as a current mineral resource. The Company further notes that the Grease River Project claims are located along trend of the deposit to the southwest and northeast. Limited exploration has been conducted in the Grease River Project area. *Homeniuk, L A, Clark, R. J., and Bonnar, R., Eldorado Nuclear Limited, CIM Bulletin May,1982. “Fond-du-Lac uranium deposit” Qualified Person The technical content of this news release has been reviewed and approved by Rebecca Hunter, Ph.D., P. Geo., who is a Qualified Person as defined by National Instrument 43-101, Standards of Disclosure for Mineral Projects. The information provides an indication of the exploration potential of the Property but may not be representative of expected results. About Forum Energy Metals Forum Energy Metals Corp. (TSX.V: FMC OTCQB: FDCFF) is focused on the discovery of high grade unconformity-related uranium deposits in the Athabasca Basin, Saskatchewan and the Thelon Basin, Nunavut. In addition, Forum holds a diversified energy metal portfolio of copper, nickel, and cobalt projects in Saskatchewan and Idaho. For further information: https://www.forumenergymetals.com. About Traction Uranium Corp. Traction Uranium Corp. (CSE: TRAC) (OTC: TRCTF) (FRA: Z1K) is in the business of mineral exploration and the development of discovery prospects in Canada, including its three uranium projects in the world-renowned Athabasca Region. We invite you to find out more about our exploration-stage activities across Canada’s Western region at www.tractionuranium.com. Figure 1. Location of the Grease River Project (West and East claim blocks) in northern Saskatchewan. The closest community is the hamlet of Fond-du-Lac, which is located between the two claim blocks. The southern claim block rests within the Athabasca Basin and the northern claim block is outside the Athabasca Basin. Dashed line is the Grease River Shear Zone, a major shear system that extends for over 400 km. Unconformity uranium deposits are structurally controlled, fluids from under the Athabasca sandstone basin carrying uranium along the faults. Forum and Traction see this structure as a possible major fluid conduit that has the potential to host a significant uranium deposit. Figure 2. Total Magnetic Intensity of Grease River Project claim blocks. The red colours are magnetic highs, the blue colours magnetic lows. Unconformity deposits tend to be found in the magnetic lows, either due to the type of underlying rocks (metasediments) or fault zones. Figure 3. Time slice (dB/dT channel 15) from the TDEM channel data showing the main northeast-trending conductors in the East claim block in the red/pink colours. Further exploration will concentrate on the combination of the high conductive zones, low-magnetic fault intersections and radiometric highs, all delineated by the Axiom airborne survey. Further ground work is planned for 2024, which will establish drill targets. ON BEHALF OF THE BOARD OF DIRECTORS Richard J. Mazur, P.Geo. President & CEO Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. For further information contact: Rick Mazur, P.Geo., President & CEO mazur@forumenergymetals.com Tel: 604-630-1585 SOURCE